血清BAFF在系统性红斑狼疮的表达及临床意义
详细信息    查看全文 | 推荐本文 |
  • 英文篇名:The Levels and Clinical Significance of B Cell Activating Factor in Systemic Lupus Erythematosus
  • 作者:黄惠娟 ; 俞烜华
  • 英文作者:HUANG Huijuan;YU Xuanhua;People's Hospital Affiliated to Fujian University of Traditional Chinese Medicine;
  • 关键词:红斑狼疮 ; 系统性 ; SLEDAI ; BAFF ; 抗ds-DNA抗体
  • 英文关键词:BAFF;;Lupus erythematosus;;Systemic;;SLEDAI;;Anti-ds DNA antibody
  • 中文刊名:YJZY
  • 英文刊名:Chinese and Foreign Medical Research
  • 机构:福建中医药大学附属人民医院;
  • 出版日期:2018-09-05
  • 出版单位:中外医学研究
  • 年:2018
  • 期:v.16;No.393
  • 语种:中文;
  • 页:YJZY201825007
  • 页数:2
  • CN:25
  • ISSN:23-1555/R
  • 分类号:21-22
摘要
目的:检测系统性红斑狼疮(SLE)患者血清B细胞活化因子(BAFF)表达水平,探讨BAFF与SLE病情活动指标及临床症状的关系。方法:采用酶联免疫吸附法(ELISA)检测80例SLE患者及60例健康对照血清BAFF水平;检测SLE患者抗双链DNA(ds-DNA)抗体等指标。结果:SLE组血清BAFF水平高于健康对照组(P<0.05),活动组BAFF水平高于非活动组及健康对照组(P<0.01)。SLE患者血清中BAFF水平与SLEDAI、血沉(ESR)呈正相关(P<0.01、P<0.05);与补体C3呈负相关(P<0.05)。抗ds-DNA抗体阳性SLE患者BAFF水平高于抗ds-DNA抗体阴性SLE患者(P<0.01)。结论:SLE患者BAFF水平升高,提示BAFF参与SLE发病,且与SLE病情活动指标相关。
        Objective:To investigate the levels of B cell activating factor(BAFF) in systemic lupus erythematosus(SLE),and to analysis the correlation between BAFF and SLE disease activity index,clinical symptoms.Method:Serum BAFF levels were tested by Enzyme-linked immunosorbent assay(ELISA) in 80 patients with SLE and 60 healthy controls.Anti double stranded DNA(ds-DNA) antibodies in SLE patients were detected.Result:BAFF expression in SLE group was significantly higher than that in healthy control group(P<0.05);BAFF expression in activity group higher than those in non activity group and health control group(P<0.01).Serum BAFF expression was positively correlated with SLEDAI,ESR(P<0.01,P<0.05),and negatively correlated with C3(P<0.05) in SLE patients.SLE patients with positive anti-ds DNA antibody had significantly higher expression of BAFF than that with negative anti-ds DNA antibody(P<0.01).Conclusion:BAFF may be involved in SLE development,and may affected to SLE disease activity.
引文
[1]梅坚,王静,李芹,等.唑来膦酸对系统性红斑狼疮合并骨质疏松患者骨密度及骨代谢的影响[J].中国药房,2017,28(2):197-200.
    [2]王林海,刘云清.泼尼松与羟氯喹对妊娠合并系统性红斑狼疮的疗效评价[J].中外医学研究,2018,16(12):153-154.
    [3]孙天水.B细胞活化因子/增殖诱导配体系统与系统性红斑狼疮的研究进展[J].中国全科医学,2017,20(14):1769-1773.
    [4]俞烜华,许小玲,黄碧仙,等.系统性红斑狼疮中医证型与BAFF及疾病活动指标关系探讨[J].世界中医药,2016,11(11):2304-2307.
    [5]温斯健,林有坤.B淋巴细胞刺激因子及拮抗剂与系统性红斑狼疮的研究进展[J].广西医科大学学报,2014,31(1):153-156.
    [6]许小玲,俞烜华,李忆农.系统性红斑狼疮中B细胞活化因子、干扰素α的表达及临床意义[J].临床荟萃,2013,28(5):522-524,532.
    [7]许小玲,李忆农.TLR9、IFN-α和BAFF水平与系统性红斑狼疮的相关性研究[J].免疫学杂志,2014,30(11):998-1002.
    [8]孙明姝,王新云,张云清,等.系统性红斑狼疮病人血清BAFF及IL-17水平及意义[J].青岛大学医学院学报,2015,51(6):656-658.
    [9]许鸿昌.抗核抗体、抗-ds-DNA、抗-sm、抗核小体联合检测对SLE的诊断价值[J].中国现代医生,2016,54(7):91-93,96.
    [10]葛风梅.B细胞激活因子在风湿性疾病中的研究进展[J].滨州医学院学报,2017,40(1):62-64,68.
    [11]冯永民,陈秋萍,黄柳涛,等.活动性系统性红斑狼疮患者外周血嗜碱性粒细胞CD62L、BAFF和CD40L表达变化及意义[J].山东医药,2017,57(9):20-23.
    [12]沈思钰,朱培元,傅晓东.系统性红斑狼疮B细胞靶向治疗研究概述[J].药物流行病学杂志,2015,24(9):554-557.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700